Delivery Order SPE2DB20D3101-SPE2DB25FREJ3

Award Date 3/13/25
Potential Completion Date 3/14/25
Potential Value $2.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $8,492.31 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NITROFURANTOIN MONO-MCR 100 MG 100S, a pharmaceutical product, with a completion date of November 21, 2023. This contract award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,601.77, is for the provision of NITROFURANTOIN MONO-MCR 100 MG 100S, a pharmaceutical product. This contract is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC...
This federal contract award, valued at $5,270.17, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of NITROFURANTOIN MONO-MCR 100 MG 100S, a pharmaceutical product. The award is not associated with any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of NITROFURANTOIN MONO-MCR 100 MG 1000S. The contract has a ceiling value of $14,522.98 and is a Firm Fixed Price Delivery Order contract that runs through November 24, 2023. The award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,772.77, is for the delivery of 4563347518 - NITROFURANTOIN MONO-MCR 100 MG 100S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of January 18, 2024. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,860.92, is for the delivery of Nitrofurantoin Mono-MCR 100 mg medication. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of June 24, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $2,981.85 with a firm fixed price and an ultimate completion date of January 21, 2025. The contract is for the supply of NITROFURANTOIN MONO-MCR 100 MG 100S, a pharmaceutical product. This award is not designated as a set-aside contract. In addition to this specific Delivery Order,...
This federal contract award is for the delivery of 4,565,851,510 units of the pharmaceutical product NITROFURANTOIN MONO-MCR 100 MG 100S. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $2,547.65 and is a Firm Fixed Price Delivery Order with a completion date of September 19, 2024. The contract is not set aside for any special designation. AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,130.92, is for the delivery of Nitrofurantoin Mono-MCR 100 mg tablets, a generic antibiotic medication, to support military healthcare programs. The contract is a Delivery Order against AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award is a delivery order valued at $3,311.76 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Nitrofurantoin Mono-MCR 100 mg tablets, a generic medication used to treat urinary tract infections. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB25FREJ3
    Delivery Order

This federal contract award, valued at $2,760.45, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NITROFURANTOIN MONO-MCR 100 MG 100S, a pharmaceutical product, with a completion date of March 14, 2025.

The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 6/12/25, 10:03 AM